Experienced in Lambert-Eaton Syndrome

Suzanne Kosmider

Ballarat, VIC, AU 
Experienced in Lambert-Eaton Syndrome
Ballarat, VIC, AU 
OverviewLocationsClinical Research

Overview

Suzanne Kosmider practices in Ballarat, Australia. Ms. Kosmider is rated as an Experienced expert by MediFind in the treatment of Lambert-Eaton Syndrome. Her top areas of expertise are Colorectal Cancer, Lung Metastases, and Lambert-Eaton Syndrome.

Her clinical research consists of co-authoring 47 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 1 article in the study of Lambert-Eaton Syndrome.

Gender
Female

Locations

Ballarat, VIC, Australia
Other Locations
Western Health
Footscray, VIC, Australia
Western Health
Melbourne, VIC, Australia
Western Health, VIC, Australia
St Albans, VIC, Australia
St. Vincent's Hospital, Hobart, TAS And South West Healthcare, Warrnambool, VIC, Australia
Eastern Health
Box Hill, VIC, Australia
Parkville, VIC, Australia

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

DREAM3R: DuRvalumab (MEDI4736) With chEmotherapy as First Line treAtment in Advanced Pleural Mesothelioma - A Phase 3 Randomised Trial
DREAM3R: DuRvalumab (MEDI4736) With chEmotherapy as First Line treAtment in Advanced Pleural Mesothelioma - A Phase 3 Randomised Trial
Enrollment Status: Completed
Publish Date: July 18, 2025
Intervention Type: Drug
Study Drug: Durvalumab
Study Phase: Phase 3

47 Total Publications

Exploring Real-World Outcomes of First Line EGFR Inhibitor Use, Cetuximab Versus Panitumumab, in Patients with Left-Sided, RAS Wild-Type, Metastatic Colorectal Cancer.
Exploring Real-World Outcomes of First Line EGFR Inhibitor Use, Cetuximab Versus Panitumumab, in Patients with Left-Sided, RAS Wild-Type, Metastatic Colorectal Cancer.
Journal: Clinical colorectal cancer
Published: February 25, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Kosmider's expertise for a condition
ConditionClose
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile